找回密码
 立即注册

微信扫码登录

搜索

[NCCN非小细胞肺癌] IIIB期(T4 N2);IIIC期(T4 N3);IVA期(M1a)胸腔积液或心包积液(NSCL-14)

[复制链接]
阳光肺科 发表于 2026-6-25 03:07:05 | 显示全部楼层 |阅读模式

马上注册,阅读更多内容,享用更多功能!

您需要 登录 才可以下载或查看,没有账号?立即注册

×
评估和治疗:IIIB期(T4 N2);IIIC期(T4 N3);IVA期(M1a)胸腔积液或心包积液(NSCL-14)
202607251344253278.jpg
l FDG-PET/CT performed skull base to mid-thigh. Positive FDG-PET/CT scan findings for mediastinal nodal or distant disease need pathologic or other radiologic confirmation. If FDG-PET/CT scan is positive in the mediastinum, lymph node status needs pathologic confirmation.
o 放射治疗原则(NSCL-C) .
s If MRI is not possible, CT of head with contrast.
w 同步放化疗方案(NSCL-F).
z For patients who have received sequential chemoradiation, durvalumab can be considered as consolidation immunotherapy or, if EGFR exon 19 deletion or L858R mutation, osimertinib is recommended.
ii Most pleural (pericardial) effusions with lung cancer are a result of the tumor. In a few patients, however, multiple microscopic examinations of pleural (pericardial) fluid are negative for tumor, and fluid is non-bloody and not an exudate. If these elements and clinical judgment dictate that the effusion is not related to the tumor, the effusion should be excluded as a staging descriptor.

NCCN-NSCLC-2026V6   

NCCN非小细胞肺癌指南导航  
 楼主| 阳光肺科 发表于 2026-6-25 16:46:50 | 显示全部楼层
游客,您所在的用户组(游客)暂无权限查看回复内容,请微信注册本站

给我们建议|手机版|阳光肺科 ( 粤ICP备2020077405号-1 )

GMT+8, 2026-7-29 07:43

Powered by Discuz! X3.5

© 2001-2026 Discuz! Team.

快速回复 返回顶部 返回列表